The clinical trialist emphasized need for stellate neuron-specific readouts beyond global cognitive measures, but no validated biomarkers exist. This represents a critical bottleneck for translating any therapeutic hypothesis into successful clinical trials. Source: Debate session sess_sda-2026-04-01-gap-004 (Analysis: sda-2026-04-01-gap-004)
Landscape Summary: Can stellate neuron-specific biomarkers predict therapeutic response in early AD intervention trials? is a 0.75 priority gap in clinical research. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
Can stellate neuron-specific biomarkers predict therapeutic response in early AD intervention trials? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: